Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia.
Russo D, Pricolo G, Michieli M, Michelutti A, Raspadori D, Bertone A, Marin L, Pierri I, Bucalossi A, Zuffa E, De Vivo A, Mazza P, Gobbi M, Lauria F, Zaccaria A, Baccarani M.
Russo D, et al. Among authors: zuffa e.
Leuk Lymphoma. 2001 Jan;40(3-4):335-43. doi: 10.3109/10428190109057932.
Leuk Lymphoma. 2001.
PMID: 11426555
Clinical Trial.